Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trial

Published:2011-02-02 Issue:1 Volume:12 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Heemskerk Dorothee,Day Jeremy,Chau Tran Thi Hong,Dung Nguyen Huy,Yen Nguyen Thi Bich,Bang Nguyen Duc,Merson Laura,Olliaro Piero,Pouplin Thomas,Caws Maxine,Wolbers Marcel,Farrar Jeremy

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/article/10.1186/1745-6215-12-25/fulltext.html

Reference41 articles.

1. Rich CB, Samuels AJ: Tuberculous meningitis treated with streptomycin. Can Med Assoc J. 1948, 58 (3): 282-4.

2. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ: Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004, 351 (17): 1741-51. 10.1056/NEJMoa040573.

3. Torok ME, Chau TT, Mai PP, Phong ND, Dung NT, Chuong LV, Lee SJ, Caws M, de Jong MD, Hien TT, Farrar JJ: Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS ONE. 2008, 3 (3): e1772-10.1371/journal.pone.0001772.

4. Garg RK: Tuberculosis of the central nervous system. Postgrad Med J. 1999, 75 (881): 133-40.

5. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR, ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee: An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006, 174 (8): 935-52. 10.1164/rccm.200510-1666ST.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The diagnosis of tuberculous meningitis: advancements in new technologies and machine learning algorithms;Frontiers in Microbiology;2023-10-24

2. Mathematical Model for Growth and Rifampicin-Dependent Killing Kinetics of Escherichia coli Cells;ACS Omega;2023-10-05

3. High‐dose rifampicin for the treatment of tuberculous meningitis: a meta‐analysis of randomized controlled trials;Journal of Clinical Pharmacy and Therapeutics;2021-12-12

4. A Bayesian analysis of the association between Leukotriene A4 Hydrolase genotype and survival in tuberculous meningitis;eLife;2021-01-08

5. Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis;Clinical Infectious Diseases;2020-09-28